1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
Asia Pacific Radiofrequency Ablation Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Application, and Geography

Asia Pacific Radiofrequency Ablation Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Application, and Geography

  • May 2020
  • 109 pages
  • ID: 5894520
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Apr 20th 2021


Table of Contents

Search Inside

Asia Pacific Radiofrequency Ablation Devices Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Product and Application
The Asia Pacific radiofrequency ablation devices market is anticipated to reach US$ 1,705.06 Mn by 2027 from US$ 699.62 Mn in 2019. The market is projected to grow at a CAGR of 12.1% from 2020 to 2027. In a radiofrequency ablation procedure, the physicians use a device that transmits the energy of radiofrequency waves and destroys the target tissue. This technology has been widely in use to treat solid tumors, arrhythmias, uterine fibroids, and other medical conditions. The radiofrequency ablation devices market growth is primarily attributed to the rising prevalence of chronic diseases, emerging applications of radiofrequency ablation technology, and increasing preference for minimally invasive procedures in Asia Pacific. However, side-effects associated with radiofrequency ablation, and high tendency of reusing and reprocessing the devices due to the high cost of new devices hamper the growth of the market in this region. Additionally, business expansion in emerging markets in Asia Pacific, and consistent radiofrequency ablation product launches and approvals provide opportunities to the market player to grow their presence in this region during the forecast period.

Increasing the prevalence of chronic pain conditions such as arthritis, combined with osteoporosis, is likely to drive the market development in the coming years.Chronic pain is long-lasting and is resilient to most medical treatments; it might lead to severe physiological and mental problems that affect the quality of life.

In 2008, the prevalence of arthritis in China was 31.4% of the total population in middle-aged people or older. Moreover, as per Chinese Census 2010, there were 526 million cases of atrial fibrillation in China. The growing geriatric population, coupled with rising life expectancy, is expected to boost the healthcare sector growth in the region during the forecast period. Geriatric people are more prone to chronic diseases, driving the demand for highly effective treatments, such as RF ablation. For instance, ~40% people in Japan are likely to age more than 65 by 2060. The demographics tend to have maximum need for adequate care and treatment due to highest disability rate, which is anticipated to propel the growth of the market for new therapeutic technologies such as radiofrequency ablation. Pain leads to severe complications if proper care or treatment is not taken for a long time. Highly adverse effects and lower efficiency of alternate pain relief procedures and therapeutics such as opioids, acupuncture, and acupressure have led to the surge in the adoption of radiofrequency ablation devices. Hence, high availability, easy access, increased awareness, cost-effectiveness, and quick relief provide RF ablation devices a cutting edge over other treatment options for pain management.
Radiofrequency ablation is an effective treatment for chronic pain management and small cancers, and the procedure can be repeated in case of reoccurrence of cancer.Rising chronic pain disorders such as arthritis and osteoporosis, coupled with improving healthcare infrastructure, would propel the market growth in the coming years.

The high success rate of radio frequency ablation in cancer treatment and advantages offered (such as generation of larger ablation zones and less impact of the heat sink effect) are the major factors contributing to the growth of radiofrequency ablation devices market. The radiofrequency ablation technology has gained a lot of attention in applications such as pain management and dermatology, and it is also widely being used in gynecology to treat uterine fibroids.
In 2019, the disposables segment accounted for a larger share of the radiofrequency ablation devices market in Asia Pacific, based on product.Disposables help in transmitting the electric current to the target tissue and, hence, are the crucial component of the radiofrequency ablation procedure.

In addition, advanced technology with the capability of creating large regions of coagulative necrosis in a controlled manner, with the positive effects of low toxicity and minimized risk of complication is driving the growth of the disposable radiofrequency ablation devices market. Moreover, the market players are developing innovative products to reduce errors and carry out the procedure efficiently.
In 2019, the surgical oncology segment held the largest share of the Asia Pacific radiofrequency ablation devices market, by application, in 2019. However, the cardiology segment is estimated to register the highest CAGR of 12.8% in the market during the forecast period. The RFA technology has been widely used in the surgical oncology. It has been widely in use in the surgical oncology; the procedure involves using heat and electrical current to destroy cancer cells. The technology is also used to treat Barrett’s esophagus, which is the precancerous condition of the esophagus. Thus, wide application of RFA in surgical oncology and increasing number of cancer patients is contributing a significant market share to the radiofrequency ablation devices market, and the trend expected to continue during the forecast period.
The countries in Asia Pacific are witnessing huge challenge currently due to growing COVID-19 infection spread.The healthcare sectors in respective countries have been hit adversely due to this outbreak, especially as a result of collapsing economies.

Restrictive measures have been taken to control the spread of the COVID-19; however, with the most focus on the management of this disease, the treatment of patients with cancer, and cardiologic and gynecological conditions has ultimately become the second priority, which is putting the demand for radiofrequency ablation procedures down.
A few of the significant secondary sources studied for preparing the Asia Pacific radiofrequency ablation device market report are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Chinese Census, Malaysia Healthcare Travel Council and National Family Health Survey (India).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Oncology Information System Market by Software, Application, Enduser - Global Forecast to 2025

  • $ 4950
  • February 2021
  • 259 pages

The oncology information systems market is projected to reach USD 9.5 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 7.4% during the forecast period. Growth of the market is mainly attributed ...

  • World
  • United States
  • Healthcare
  • Patient Data Management
  • Industry analysis
  • Medical Technology Density
  • Health Expenditure


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on